CHRB(CHRB)
CHRB
No analyst ratings available
No analyst price targets available for CHRB
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2026E |
|---|---|
| Revenue Avg | $538M |
| Low | $538M |
| High | $538M |
| EBITDA Avg | — |
| Low | — |
| High | — |
| EBIT Avg | — |
| Low | — |
| High | — |
| Net Income Avg | — |
| Low | — |
| High | — |
| EPS Avg | — |
| Low | — |
| High | — |
| Analysts (Rev / EPS) | 1 / — |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 | Q1 2028 | Q2 2028 |
|---|---|---|---|---|---|---|---|---|
| Revenue Avg | $75M | $77M | $84M | $66M | $79M | $80M | $84M | $69M |
| Low | $75M | $77M | $84M | $66M | $79M | $80M | $84M | $69M |
| High | $75M | $77M | $84M | $66M | $79M | $80M | $84M | $69M |
| EBITDA Avg | $3M | $3M | $8M | $-1M | $-2M | $-5M | $-10M | $-4M |
| Low | $3M | $3M | $8M | $-1M | $-2M | $-5M | $-10M | $-4M |
| High | $3M | $3M | $8M | $-1M | $-2M | $-5M | $-10M | $-4M |
| EBIT Avg | $-3M | $-3M | $3M | $-7M | $-7M | $-10M | $-15M | $-8M |
| Low | $-3M | $-3M | $3M | $-7M | $-7M | $-10M | $-15M | $-8M |
| High | $-3M | $-3M | $3M | $-7M | $-7M | $-10M | $-15M | $-8M |
| Net Income Avg | $-3M | $-3M | $2M | $-7M | $-7M | $-10M | $-15M | $-8M |
| Low | $-3M | $-3M | $2M | $-7M | $-7M | $-10M | $-15M | $-8M |
| High | $-3M | $-3M | $2M | $-7M | $-7M | $-10M | $-15M | $-8M |
| EPS Avg | $-1.00 | $-0.90 | $0.65 | $-1.95 | $-2.10 | $-3.10 | $-4.34 | $-2.51 |
| Low | $-1.00 | $-0.90 | $0.65 | $-1.95 | $-2.10 | $-3.10 | $-4.34 | $-2.51 |
| High | $-1.00 | $-0.90 | $0.65 | $-1.95 | $-2.10 | $-3.10 | $-4.34 | $-2.51 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 |